<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/DDD14154-81FB-417E-81AA-AAEA066ECA04"><gtr:id>DDD14154-81FB-417E-81AA-AAEA066ECA04</gtr:id><gtr:name>The Wellcome Trust  Sanger Institute</gtr:name><gtr:address><gtr:line1>Wellcome Trust Genome Campus</gtr:line1><gtr:line2>Hinxton</gtr:line2><gtr:postCode>CB10 1SA</gtr:postCode><gtr:region>East of England</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/F5B83740-823A-461B-AEB6-0DCFED1739C8"><gtr:id>F5B83740-823A-461B-AEB6-0DCFED1739C8</gtr:id><gtr:name>Kyoto University</gtr:name><gtr:address><gtr:line1>Nishikyo-ku</gtr:line1><gtr:line2>Katsura Campus</gtr:line2><gtr:line4>Kyoto</gtr:line4><gtr:line5>Kyoto, 615-8540</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>Japan</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/AB7C0822-BBCB-4C61-85EC-5D13C7A31759"><gtr:id>AB7C0822-BBCB-4C61-85EC-5D13C7A31759</gtr:id><gtr:name>MRC Laboratory of Molecular Biology</gtr:name><gtr:address><gtr:line1>Hills Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 2QH</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/AB7C0822-BBCB-4C61-85EC-5D13C7A31759"><gtr:id>AB7C0822-BBCB-4C61-85EC-5D13C7A31759</gtr:id><gtr:name>MRC Laboratory of Molecular Biology</gtr:name><gtr:address><gtr:line1>Hills Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 2QH</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/DDD14154-81FB-417E-81AA-AAEA066ECA04"><gtr:id>DDD14154-81FB-417E-81AA-AAEA066ECA04</gtr:id><gtr:name>The Wellcome Trust  Sanger Institute</gtr:name><gtr:address><gtr:line1>Wellcome Trust Genome Campus</gtr:line1><gtr:line2>Hinxton</gtr:line2><gtr:postCode>CB10 1SA</gtr:postCode><gtr:region>East of England</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/F5B83740-823A-461B-AEB6-0DCFED1739C8"><gtr:id>F5B83740-823A-461B-AEB6-0DCFED1739C8</gtr:id><gtr:name>Kyoto University</gtr:name><gtr:address><gtr:line1>Nishikyo-ku</gtr:line1><gtr:line2>Katsura Campus</gtr:line2><gtr:line4>Kyoto</gtr:line4><gtr:line5>Kyoto, 615-8540</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>Japan</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/15049CCE-73FD-49A7-A723-53B6B9890692"><gtr:id>15049CCE-73FD-49A7-A723-53B6B9890692</gtr:id><gtr:firstName>Julian</gtr:firstName><gtr:surname>Sale</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MC_U105178808"><gtr:id>226A4BEF-A8FF-4E6F-8824-E0B5EC217723</gtr:id><gtr:title>Vertebrate mutagenesis and DNA damage tolerance</gtr:title><gtr:status>Active</gtr:status><gtr:grantCategory>Intramural</gtr:grantCategory><gtr:grantReference>MC_U105178808</gtr:grantReference><gtr:abstractText>The lab is trying to understand how problems encountered as cells replicate their DNA lead to mutations and to epigenetic alterations which cause changes in the pattern of gene expression in cells, sometimes known as epimutations. Both mutations and epimutations are seen extensively in cancer cells and drive the development of the disease, so understanding their origin is central to understanding how cancer arises. 
DNA can be damaged and can also fold into secondary structures, especially when it is unwound. Both can lead to interruption of DNA replication. Rescuing DNA synthesis in these circumstances requires the complex interaction of many proteins. Our primary aim is to understand how cells coordinate the replication of DNA impediments with maintaining the stability of their genomes and epigenomes. 
Our studies make use of human, mouse and avian cell lines which we can easily modify genetically. A by-product of our studies has been the development of cell lines and techniques for the in vitro evolution of antibodies and other proteins to have specific binding characteristics, a technique that can be used to generate molecules of therapeutic utility.</gtr:abstractText><gtr:technicalSummary>The group studies how problems encountered during DNA replication lead to both genetic mutation and to epimutation, changes in gene expression caused by local alterations in the chromatin of somatic cells. 

DNA replication is readily interrupted by DNA damage and by naturally occurring secondary structures in the DNA. DNA damage frequently stalls the replicative DNA polymerases but can be replicated by specialised translesion DNA polymerases, which possess active sites that are capable of accommodating damaged or distorted DNA templates. While the use of these polymerases allows replication to be completed it also increases the chance of mutagenesis. A major goal of the lab has been to understand how and when these enzymes are deployed and how their activity is regulated to allow efficient and safe replication of damaged DNA.

We have shown that in addition to assisting in the replication of damaged DNA, some specialised polymerases, acting in concert with specialised DNA helicases, also play a role in the replication of DNA secondary structures. We have shown how one type of DNA secondary structure, the G-quadruplex, stall DNA replication, interrupt histone recycling and locally prevent the proper inheritance of histone modifications through cell division leading to altered gene expression. This observation has linked replication stress to disruption of epigenetic memory and to variations in gene expression, a feature of many cancer cells. We are working to further understand how DNA replication impediments impair epigenetically encoded transcriptional memory and the circumstances in which loss of coupling between DNA replication and the propagation of epigenetic information leads to disease.

Finally, our work, which predominantly uses somatic cell genetics, has also led to the identification and development of cell lines capable of continuous mutagenesis which we have used to evolve specific antibody specificities and other proteins of therapeutic interest.</gtr:technicalSummary><gtr:fund><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2005-01-01</gtr:start><gtr:type>EXPENDITURE_ACTUAL</gtr:type><gtr:valuePounds>6554840</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Cambridge</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Chemistry</gtr:department><gtr:description>Balasubramanian</gtr:description><gtr:id>BF506FF6-CB98-46D8-9CE8-7C6FD19C6772</gtr:id><gtr:impact>Publication: Sarkies, P., Murat, P., Phillips, L.G., Patel, K.J., Balasubramanian, S. and Sale, J.E.&amp;para; (2011). FANCJ coordinates two pathways that maintain epigenetic stability at G-quadruplex DNA. Nucleic Acids Research DOI 10.1093/nar/gkr868.</gtr:impact><gtr:outcomeId>UBYz3zqbYaA-1</gtr:outcomeId><gtr:partnerContribution>Provided expertise in biophysics of G quadruplexes and compounds that can stabilise these structures</gtr:partnerContribution><gtr:piContribution>Examining impact of G-quadruplex stabilising ligands on epigenetic instability, combining our cell line models with the expertise of our chemist collaborators, Professor Shankar Balasubramanian &amp;amp; Dr. Pierre Murat, in biophysics of G quadruplexes and synthesis of G quadruplex ligands</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>The Wellcome Trust Sanger Institute</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>COMSIG consortium</gtr:description><gtr:id>C56C60E4-3E24-4525-A4AB-198F015C0062</gtr:id><gtr:impact>x</gtr:impact><gtr:outcomeId>546132fca55605.19191381-1</gtr:outcomeId><gtr:partnerContribution>Steve Jackson, Gurdon Institute and Michael Stratton, Sanger Centre run the project, providing personnel, grant administration, space and equipment.</gtr:partnerContribution><gtr:piContribution>Named investigator on Wellcome Trust COMSIG consortium, which is a multi centre and multi disciplinary grant to investigate the origins of mutational signatures. We have provided constructs and scientific advice.</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Cambridge</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Gurdon Institute</gtr:department><gtr:description>COMSIG consortium</gtr:description><gtr:id>4F0F177C-CA97-46EB-935C-A6A3D8A86924</gtr:id><gtr:impact>x</gtr:impact><gtr:outcomeId>546132fca55605.19191381-2</gtr:outcomeId><gtr:partnerContribution>Steve Jackson, Gurdon Institute and Michael Stratton, Sanger Centre run the project, providing personnel, grant administration, space and equipment.</gtr:partnerContribution><gtr:piContribution>Named investigator on Wellcome Trust COMSIG consortium, which is a multi centre and multi disciplinary grant to investigate the origins of mutational signatures. We have provided constructs and scientific advice.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Kyoto</gtr:collaboratingOrganisation><gtr:country>Japan</gtr:country><gtr:department>Department of Radiation Genetics</gtr:department><gtr:description>Takeda</gtr:description><gtr:id>BC44DE89-ECEB-4E90-8F40-2AB055B1BB3D</gtr:id><gtr:impact>16923963 17283053 18662998</gtr:impact><gtr:outcomeId>C569C27F5E7-1</gtr:outcomeId><gtr:partnerContribution>exchange of cell lines</gtr:partnerContribution><gtr:piContribution>exchange of cell lines, data and ideas</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>LMB Open Day 2013 - Chairing Public Lectures</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>6843AEB3-25F6-432A-B8E6-01A17629A045</gtr:id><gtr:impact>Talks were followed by questions and positive comments on feedback forms about value the research and public's interest in it

Requests for similar events. Better levels of understanding (from feedback forms).</gtr:impact><gtr:outcomeId>54622b155d55d7.02191695</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>LMB Open Day 2013 - Group members assisted with science demonstrations</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>E98D6D72-B04F-4407-8E87-4C477E5383EB</gtr:id><gtr:impact>Demonstrations promtped questions and requests for further information

Better understanding among public about the work of the LMB</gtr:impact><gtr:outcomeId>54622bd9990ec2.45495790</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>75000</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Fanconi Anemia Research Fund Project Grant</gtr:description><gtr:end>2013-06-02</gtr:end><gtr:fundingOrg>Fanconi Anemia Research Fund (FARF)</gtr:fundingOrg><gtr:id>FAB067E4-5D88-48C8-856A-30A84BE48413</gtr:id><gtr:outcomeId>M93zRMvBnr90</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2011-06-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>47000</gtr:amountPounds><gtr:country>Germany, Federal Republic of</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Jurgen Manchot Stiftung Studentship</gtr:description><gtr:end>2014-09-02</gtr:end><gtr:fundingOrg>Jurgen Manchot Foundation</gtr:fundingOrg><gtr:id>EB421364-2242-486E-B74E-527BCC5174D8</gtr:id><gtr:outcomeId>SscifFsG6J80</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2011-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>70000</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>EUR</gtr:currCode><gtr:currCountryCode>Austria</gtr:currCountryCode><gtr:currLang>de_AT</gtr:currLang><gtr:description>EMBO Long Term Fellowship - Schiavone</gtr:description><gtr:end>2014-05-02</gtr:end><gtr:fundingOrg>European Molecular Biology Organisation</gtr:fundingOrg><gtr:id>4CAFB343-B281-4975-8414-A254BF745100</gtr:id><gtr:outcomeId>rfBeVXDwRzq</gtr:outcomeId><gtr:sector>Learned Society</gtr:sector><gtr:start>2012-06-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1600</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Summer Studentship - Gilmartin</gtr:description><gtr:end>2016-08-02</gtr:end><gtr:fundingOrg>Biochemical Society</gtr:fundingOrg><gtr:id>02ECF29C-1F67-4C07-954E-79B31E874B17</gtr:id><gtr:outcomeId>58bec61746ad96.01900978</gtr:outcomeId><gtr:sector>Learned Society</gtr:sector><gtr:start>2016-07-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>110000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Darwin Trust of Edinburgh</gtr:department><gtr:description>Cesar Milstein Studentship</gtr:description><gtr:end>2018-12-02</gtr:end><gtr:fundingOrg>British Society for the History of Science (BSHS)</gtr:fundingOrg><gtr:id>054796BC-4431-4F1C-8188-8DF62B464D65</gtr:id><gtr:outcomeId>5461e3be284374.74511257</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>200168</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Research and Development AstraZeneca</gtr:department><gtr:description>AstraZeneca/LMB Blue Skies Initiative</gtr:description><gtr:end>2017-05-02</gtr:end><gtr:fundingOrg>AstraZeneca</gtr:fundingOrg><gtr:id>B06D7035-BBD2-4C0A-9BA2-B6DBAF9D7C33</gtr:id><gtr:outcomeId>56dcb7ad6dbb58.03474772</gtr:outcomeId><gtr:sector>Private</gtr:sector><gtr:start>2015-05-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>96000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Darwin Trust of Edinburgh</gtr:department><gtr:description>Cesar Milstein Studentship</gtr:description><gtr:end>2015-12-02</gtr:end><gtr:fundingOrg>British Society for the History of Science (BSHS)</gtr:fundingOrg><gtr:id>F13238A8-9286-454F-A693-21F9695960D2</gtr:id><gtr:outcomeId>5461e334dd2818.67177445</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>200000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wellcome Trust TMAT Studentship</gtr:description><gtr:end>2014-09-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>D9A23DC0-67FA-4685-A74E-FE26ECE9777C</gtr:id><gtr:outcomeId>kL1qWHJr5sD0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2011-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>144710</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>AICR Project Grant</gtr:description><gtr:end>2014-12-02</gtr:end><gtr:fundingOrg>Association for International Cancer Research (AICR)</gtr:fundingOrg><gtr:fundingRef>11-0514</gtr:fundingRef><gtr:id>7752350D-898A-49F9-934B-27A1D7F5E44D</gtr:id><gtr:outcomeId>E1X99WhaNmK0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2011-06-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>127951</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>AICR Project Grant</gtr:description><gtr:end>2011-06-02</gtr:end><gtr:fundingOrg>Association for International Cancer Research (AICR)</gtr:fundingOrg><gtr:id>01174CB7-FB19-496E-89B9-024F3D7570FC</gtr:id><gtr:outcomeId>A12FECE862B0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2008-07-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>70000</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>EMBO Long Term Fellowship - Yulzary</gtr:description><gtr:end>2012-06-02</gtr:end><gtr:fundingOrg>European Molecular Biology Organisation</gtr:fundingOrg><gtr:id>35BC2E63-E996-48EF-A6FF-26CA07CFB0E9</gtr:id><gtr:outcomeId>LG2477e5eE40</gtr:outcomeId><gtr:sector>Learned Society</gtr:sector><gtr:start>2010-07-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs><gtr:intellectualPropertyOutput><gtr:description>The discovery of cell lines undergoing constitutive immunoglobulin hypermutation &amp;amp; a method to select antibodies of a desired affinity from a pool such cells. Filed under: Sale, J.E., Neuberger, M.S. and Cumbers S.J. (2000). 'Method for generating diversity' PCT/GB99/03358 WO 00/22111 Medical Research Council, U.K. Sale, J.E. and Neuberger, M.S. (2001). 'Method for generating diversity' CIP. Medical Research Council, U.K.</gtr:description><gtr:grantRef>MC_U105178808</gtr:grantRef><gtr:id>10739F6A-2B9C-4812-8AAD-7ED3D3E38C62</gtr:id><gtr:impact>Licensed by MRC to Anaptys Inc., I understand.</gtr:impact><gtr:licensed>Yes</gtr:licensed><gtr:outcomeId>s7dPEiz2rz2</gtr:outcomeId><gtr:patentId>US2008193979</gtr:patentId><gtr:protection>Patent granted</gtr:protection><gtr:title>Antibody selection from hypermutating cell lines</gtr:title><gtr:yearProtectionGranted>2008</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput><gtr:intellectualPropertyOutput><gtr:description>The discovery of cell lines undergoing constitutive immunoglobulin hypermutation &amp;amp; a method to select antibodies of a desired affinity from a pool such cells. Filed under: Sale, J.E., Neuberger, M.S. and Cumbers S.J. (2000). 'Method for generating diversity' PCT/GB99/03358 WO 00/22111 Medical Research Council, U.K. Sale, J.E. and Neuberger, M.S. (2001). 'Method for generating diversity' CIP. Medical Research Council, U.K.</gtr:description><gtr:grantRef>MC_U105178808</gtr:grantRef><gtr:id>176C9C7D-0362-4FB6-A30C-CAB9E1DC8990</gtr:id><gtr:impact>Licensed by MRC to Anaptys Inc., I understand.</gtr:impact><gtr:licensed>Yes</gtr:licensed><gtr:outcomeId>9C382D5DF6F</gtr:outcomeId><gtr:patentId>EP2204447</gtr:patentId><gtr:protection>Patent granted</gtr:protection><gtr:title>Antibody selection from hypermutating cell lines</gtr:title><gtr:yearProtectionGranted>2010</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput><gtr:intellectualPropertyOutput><gtr:description>An Ang-2 specific ligand trap developed by directed evolution in a hypermutating cell line. A potential therapeutic with applications in cancer, inflammatory disease and sepsis.</gtr:description><gtr:grantRef>MC_U105178808</gtr:grantRef><gtr:id>417A3CF5-8E3D-402C-8D59-22A6D2F7B810</gtr:id><gtr:impact>Too early to say</gtr:impact><gtr:licensed>No</gtr:licensed><gtr:outcomeId>546134b87b2674.82637745</gtr:outcomeId><gtr:patentId>WO2014096855 (A1)</gtr:patentId><gtr:protection>Patent application published</gtr:protection><gtr:title>ANGIOPOIETIN-2 SPECIFIC TIE2 RECEPTOR</gtr:title><gtr:yearProtectionGranted>2014</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput></gtr:intellectualPropertyOutputs><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs><gtr:productOutput><gtr:description>In collaboration with Prof Nick Brindle (University of Leicester), who joined the lab as a sabbatical visitor for a year, we used directed evolution in DT40 cells to evolve a ligand trap for Angiopoietin II (see Brindle, Sale et al JBC 2013 PMID: 24106271). Nick is continuing to study and develop the molecule in mouse models in Leicester, and we are seeking to further develop it with the help of MRCT. A patent application was submitted by MRCT in Dec 2012.</gtr:description><gtr:id>BFBD1F9C-1861-406E-B796-464583962DCB</gtr:id><gtr:impact>This is the first ligand trap for Ang II and as such has great therapeutic potential in inflammatory and malignant diseases.</gtr:impact><gtr:outcomeId>rjeCEmCdf7o</gtr:outcomeId><gtr:stage>Initial development</gtr:stage><gtr:status>Actively seeking support</gtr:status><gtr:title>Angiopoieitin 2 ligand trap</gtr:title><gtr:type>Therapeutic Intervention - Cellular and gene therapies</gtr:type><gtr:yearDevCompleted>2012</gtr:yearDevCompleted></gtr:productOutput></gtr:productOutputs><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>8D444672-694B-43E2-B256-E727DBC2A609</gtr:id><gtr:title>Cooperative roles of vertebrate Fbh1 and Blm DNA helicases in avoidance of crossovers during recombination initiated by replication fork collapse.</gtr:title><gtr:parentPublicationTitle>Molecular and cellular biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fd490244a2e75e7287dd734e3d716204"><gtr:id>fd490244a2e75e7287dd734e3d716204</gtr:id><gtr:otherNames>Kohzaki M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0270-7306</gtr:issn><gtr:outcomeId>926D792033C</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C31985FC-58EE-4CC1-9AD1-A8C6B09A9F1D</gtr:id><gtr:title>REV1 restrains DNA polymerase zeta to ensure frame fidelity during translesion synthesis of UV photoproducts in vivo.</gtr:title><gtr:parentPublicationTitle>Nucleic acids research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4e0fdc2a29fb7b10e8080bf594637d9e"><gtr:id>4e0fdc2a29fb7b10e8080bf594637d9e</gtr:id><gtr:otherNames>Sz?ts D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0305-1048</gtr:issn><gtr:outcomeId>0A6DC9F155E</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DF7BDE1D-9ACC-4CF3-B878-8B20B14F8859</gtr:id><gtr:title>PCNA ubiquitination and REV1 define temporally distinct mechanisms for controlling translesion synthesis in the avian cell line DT40.</gtr:title><gtr:parentPublicationTitle>Molecular cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9b3b886cd3f938e55498b5f7d5505327"><gtr:id>9b3b886cd3f938e55498b5f7d5505327</gtr:id><gtr:otherNames>Edmunds CE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1097-2765</gtr:issn><gtr:outcomeId>6FF135DF973</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6B797391-9297-4970-891E-E76302C8132F</gtr:id><gtr:title>The role of HERC2 and RNF8 ubiquitin E3 ligases in the promotion of translesion DNA synthesis in the chicken DT40 cell line.</gtr:title><gtr:parentPublicationTitle>DNA repair</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7c74602269083f66813d051be81fa161"><gtr:id>7c74602269083f66813d051be81fa161</gtr:id><gtr:otherNames>Mohiuddin</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1568-7856</gtr:issn><gtr:outcomeId>58b06e3bdd0069.45034651</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>81B5652C-26A5-4D12-BBB8-2FD8841E0FD5</gtr:id><gtr:title>Histone H3.3 promotes IgV gene diversification by&amp;nbsp;enhancing formation of AID-accessible single-stranded DNA.</gtr:title><gtr:parentPublicationTitle>The EMBO journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/470cb8d14eadc316057bcfcb264581f5"><gtr:id>470cb8d14eadc316057bcfcb264581f5</gtr:id><gtr:otherNames>Romanello M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0261-4189</gtr:issn><gtr:outcomeId>58b06e3c981742.30194651</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A2635CE3-BC1F-4171-B71F-6038DB69C6B7</gtr:id><gtr:title>The Effects of Replication Stress on S Phase Histone Management and Epigenetic Memory.</gtr:title><gtr:parentPublicationTitle>Journal of molecular biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/47af0af9c9e45c5b613e7fbb26fea9de"><gtr:id>47af0af9c9e45c5b613e7fbb26fea9de</gtr:id><gtr:otherNames>?vikovic S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0022-2836</gtr:issn><gtr:outcomeId>58b06e3cebd1b9.25694930</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B72D29F5-C703-4B5F-9E46-279FC15BF4F1</gtr:id><gtr:title>REV3 and REV1 play major roles in recombination-independent repair of DNA interstrand cross-links mediated by monoubiquitinated proliferating cell nuclear antigen (PCNA).</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/71d2de7435318637ede67099f366d8c7"><gtr:id>71d2de7435318637ede67099f366d8c7</gtr:id><gtr:otherNames>Shen X</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>722A6CEB5BD</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CD19083F-5D9E-4CF4-88DF-7462296413D7</gtr:id><gtr:title>Cells deficient in the FANC/BRCA pathway are hypersensitive to plasma levels of formaldehyde.</gtr:title><gtr:parentPublicationTitle>Cancer research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a12d6c8c7755cbc0f0bdfe9af6ad9695"><gtr:id>a12d6c8c7755cbc0f0bdfe9af6ad9695</gtr:id><gtr:otherNames>Ridpath JR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0008-5472</gtr:issn><gtr:outcomeId>2FD6DFF4D86</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>86E50993-6B4B-4DDB-B91E-F3B149654406</gtr:id><gtr:title>Clock-like mutational processes in human somatic cells.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f21d4e7b608105bff5875ac743fee92a"><gtr:id>f21d4e7b608105bff5875ac743fee92a</gtr:id><gtr:otherNames>Alexandrov LB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>564203b28aa816.68795229</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8D047CCD-A11C-40C1-801B-014749347AD0</gtr:id><gtr:title>Directed evolution of an angiopoietin-2 ligand trap by somatic hypermutation and cell surface display.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fcca5bfacb092d81cf667a5d77119229"><gtr:id>fcca5bfacb092d81cf667a5d77119229</gtr:id><gtr:otherNames>Brindle NP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>pm_14101_21_24106271</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>ACBE3448-46F0-4D1A-B863-AEF5CA177325</gtr:id><gtr:title>The catalytic activity of REV1 is employed during immunoglobulin gene diversification in DT40.</gtr:title><gtr:parentPublicationTitle>Molecular immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/459376dcc74cd8f7a2bdcaf22e8d26ed"><gtr:id>459376dcc74cd8f7a2bdcaf22e8d26ed</gtr:id><gtr:otherNames>Ross AL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0161-5890</gtr:issn><gtr:outcomeId>FB224603FB9</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6AA971F0-23E8-40D2-9CD2-BC30F23DE4D5</gtr:id><gtr:title>Retrospective. Michael Neuberger (1953-2013).</gtr:title><gtr:parentPublicationTitle>Science (New York, N.Y.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/75600966f699da66eb980b17b485574a"><gtr:id>75600966f699da66eb980b17b485574a</gtr:id><gtr:otherNames>Sale JE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0036-8075</gtr:issn><gtr:outcomeId>546136b466d486.62989128</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>616066CC-0320-4078-8E8E-52E03102E3D3</gtr:id><gtr:title>The KRAB Zinc Finger Protein Roma/Zfp157 Is a Critical Regulator of Cell-Cycle Progression and Genomic Stability.</gtr:title><gtr:parentPublicationTitle>Cell reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4c68715df7bec872efe13677d065f316"><gtr:id>4c68715df7bec872efe13677d065f316</gtr:id><gtr:otherNames>Ho TLF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:outcomeId>58b06e3c4d0874.44964519</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BA64AB94-290D-4A5D-9669-6C9C07847FC5</gtr:id><gtr:title>Directed evolution of human scFvs in DT40 cells.</gtr:title><gtr:parentPublicationTitle>Protein engineering, design &amp; selection : PEDS</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f61651130ee7c62d38b8dee3a8f60db2"><gtr:id>f61651130ee7c62d38b8dee3a8f60db2</gtr:id><gtr:otherNames>Lim AW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1741-0126</gtr:issn><gtr:outcomeId>564203b261f4f4.37017552</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4F8AF7C9-5E52-4EAF-B71D-2A48FE143407</gtr:id><gtr:title>The 9-1-1 DNA clamp is required for immunoglobulin gene conversion.</gtr:title><gtr:parentPublicationTitle>Molecular and cellular biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ff1e7eebb9258f68b07d7f0f04106099"><gtr:id>ff1e7eebb9258f68b07d7f0f04106099</gtr:id><gtr:otherNames>Saberi A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0270-7306</gtr:issn><gtr:outcomeId>AB490E96522</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0747F5FE-ED50-4697-9549-2D6388C2A96C</gtr:id><gtr:title>Unwinding to recombine.</gtr:title><gtr:parentPublicationTitle>Molecular cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b563127a0b60e70f7679847779979dc8"><gtr:id>b563127a0b60e70f7679847779979dc8</gtr:id><gtr:otherNames>Guilbaud G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1097-2765</gtr:issn><gtr:outcomeId>pm_14101_21_22920289</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>27483A1D-AB33-4547-9D07-1EEC03EC0D0E</gtr:id><gtr:title>The topography of mutational processes in breast cancer genomes.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1850dbb7e4d9b3526c6b48673d5bc82d"><gtr:id>1850dbb7e4d9b3526c6b48673d5bc82d</gtr:id><gtr:otherNames>Morganella S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn><gtr:outcomeId>58b06e3c15ba77.84690811</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E443BEEC-2103-4C61-88ED-12D1DB7D4368</gtr:id><gtr:title>Targeting BRCA1 and BRCA2 Deficiencies with G-Quadruplex-Interacting Compounds.</gtr:title><gtr:parentPublicationTitle>Molecular cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/79b689c7a0e4d8c783e7a21adaec3610"><gtr:id>79b689c7a0e4d8c783e7a21adaec3610</gtr:id><gtr:otherNames>Zimmer J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1097-2765</gtr:issn><gtr:outcomeId>58b06e3bb48732.60385852</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>49484D36-CF8E-42D3-9359-49DC5E63B7D0</gtr:id><gtr:title>Histone H3.3 is required to maintain replication fork progression after UV damage.</gtr:title><gtr:parentPublicationTitle>Current biology : CB</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/06c3320aca5c617ff9e284f707d824aa"><gtr:id>06c3320aca5c617ff9e284f707d824aa</gtr:id><gtr:otherNames>Frey A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0960-9822</gtr:issn><gtr:outcomeId>546136b4129df7.56845856</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3F4A08EA-A8C8-4F91-9937-936DD06510CA</gtr:id><gtr:title>Translesion DNA synthesis and mutagenesis in eukaryotes.</gtr:title><gtr:parentPublicationTitle>Cold Spring Harbor perspectives in biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/75600966f699da66eb980b17b485574a"><gtr:id>75600966f699da66eb980b17b485574a</gtr:id><gtr:otherNames>Sale JE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1943-0264</gtr:issn><gtr:outcomeId>pm_14101_21_23457261</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FBA0F391-5774-4C29-8A55-450421CB543E</gtr:id><gtr:title>Simultaneous disruption of two DNA polymerases, Pol? and Pol?, in Avian DT40 cells unmasks the role of Pol? in cellular response to various DNA lesions.</gtr:title><gtr:parentPublicationTitle>PLoS genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c6fd2076082c145a5903128fba5fa1ee"><gtr:id>c6fd2076082c145a5903128fba5fa1ee</gtr:id><gtr:otherNames>Hirota K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1553-7390</gtr:issn><gtr:outcomeId>iD3noGK2nnf</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E1C4D40C-24BD-4B26-9984-D0A1B52469E6</gtr:id><gtr:title>Cellular epigenetic stability and cancer.</gtr:title><gtr:parentPublicationTitle>Trends in genetics : TIG</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1822b7d57957392304cea9af011ee513"><gtr:id>1822b7d57957392304cea9af011ee513</gtr:id><gtr:otherNames>Sarkies P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0168-9525</gtr:issn><gtr:outcomeId>pm_14101_21_22226176</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D8E09B2B-813F-43DB-9520-669355507593</gtr:id><gtr:title>Deubiquitination of FANCD2 is required for DNA crosslink repair.</gtr:title><gtr:parentPublicationTitle>Molecular cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b02c22b52632b009a72cf3753ed42e7f"><gtr:id>b02c22b52632b009a72cf3753ed42e7f</gtr:id><gtr:otherNames>Oestergaard VH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1097-2765</gtr:issn><gtr:outcomeId>675CF6C61E1</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>48CD3372-3D08-4B7F-8C45-C3385A9D026F</gtr:id><gtr:title>Epigenetic instability due to defective replication of structured DNA.</gtr:title><gtr:parentPublicationTitle>Molecular cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1822b7d57957392304cea9af011ee513"><gtr:id>1822b7d57957392304cea9af011ee513</gtr:id><gtr:otherNames>Sarkies P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1097-2765</gtr:issn><gtr:outcomeId>RyVkCLFQnqo</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A6BE9C0A-7395-44C0-9786-725042BA81BF</gtr:id><gtr:title>Visualisation of PCNA monoubiquitination in vivo by single pass spectral imaging FRET microscopy.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/859160fc57e186759b647885b5e9d9e0"><gtr:id>859160fc57e186759b647885b5e9d9e0</gtr:id><gtr:otherNames>Batters C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>54622f6fd26b70.31758725</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1DDC5313-B251-4211-B7CE-4BA48F3DB485</gtr:id><gtr:title>Determinants of G quadruplex-induced epigenetic instability in REV1-deficient cells.</gtr:title><gtr:parentPublicationTitle>The EMBO journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/55d33e73a7332719a416c8408e53d407"><gtr:id>55d33e73a7332719a416c8408e53d407</gtr:id><gtr:otherNames>Schiavone D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0261-4189</gtr:issn><gtr:outcomeId>546136b43b73c9.13132840</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5C0549C8-1F23-42F4-AAC2-D0B1CC809AD4</gtr:id><gtr:title>Editorial.</gtr:title><gtr:parentPublicationTitle>Expert reviews in molecular medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/75600966f699da66eb980b17b485574a"><gtr:id>75600966f699da66eb980b17b485574a</gtr:id><gtr:otherNames>Sale JE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1462-3994</gtr:issn><gtr:outcomeId>58beae85ba7456.14607943</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0CC70CB2-2C87-43B2-A582-910E2A9B3670</gtr:id><gtr:title>Local epigenetic reprogramming induced by G-quadruplex ligands.</gtr:title><gtr:parentPublicationTitle>Nature chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b563127a0b60e70f7679847779979dc8"><gtr:id>b563127a0b60e70f7679847779979dc8</gtr:id><gtr:otherNames>Guilbaud G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1755-4330</gtr:issn><gtr:outcomeId>5a9d3668b4b8a7.48841555</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D008CD16-8C7A-4AA0-A6DD-65C0FCC56706</gtr:id><gtr:title>The Werner's Syndrome protein collaborates with REV1 to promote replication fork progression on damaged DNA.</gtr:title><gtr:parentPublicationTitle>DNA repair</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/98031bcbc54410a0dbfe127ac20a805c"><gtr:id>98031bcbc54410a0dbfe127ac20a805c</gtr:id><gtr:otherNames>Phillips LG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1568-7856</gtr:issn><gtr:outcomeId>K6wp8bPFYQa</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1E44F3DD-37AD-4F12-82E7-C7205B0F0936</gtr:id><gtr:title>Genetic evidence for single-strand lesions initiating Nbs1-dependent homologous recombination in diversification of Ig v in chicken B lymphocytes.</gtr:title><gtr:parentPublicationTitle>PLoS genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/756a84a37726b672657ee5b4f7441b7f"><gtr:id>756a84a37726b672657ee5b4f7441b7f</gtr:id><gtr:otherNames>Nakahara M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1553-7390</gtr:issn><gtr:outcomeId>hN4bgALsZAv</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>39D3F800-C87A-4C88-941C-7310B888EC49</gtr:id><gtr:title>The POLD3 subunit of DNA polymerase d can promote translesion synthesis independently of DNA polymerase ?.</gtr:title><gtr:parentPublicationTitle>Nucleic acids research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c6fd2076082c145a5903128fba5fa1ee"><gtr:id>c6fd2076082c145a5903128fba5fa1ee</gtr:id><gtr:otherNames>Hirota K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0305-1048</gtr:issn><gtr:outcomeId>564203b1d44582.90759400</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BD8C6D58-DB6C-4AA4-8B58-B1A59CF6C45A</gtr:id><gtr:title>Competition, collaboration and coordination--determining how cells bypass DNA damage.</gtr:title><gtr:parentPublicationTitle>Journal of cell science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/75600966f699da66eb980b17b485574a"><gtr:id>75600966f699da66eb980b17b485574a</gtr:id><gtr:otherNames>Sale JE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0021-9533</gtr:issn><gtr:outcomeId>pm_14101_21_22499669</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E27ECABC-B660-4152-8C1C-F89EDEE37162</gtr:id><gtr:title>PrimPol Is Required for Replicative Tolerance of G Quadruplexes in Vertebrate Cells.</gtr:title><gtr:parentPublicationTitle>Molecular cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/55d33e73a7332719a416c8408e53d407"><gtr:id>55d33e73a7332719a416c8408e53d407</gtr:id><gtr:otherNames>Schiavone D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1097-2765</gtr:issn><gtr:outcomeId>56dcb717f172b9.82958436</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>140562EA-1755-4B11-BA01-81DFAC835D83</gtr:id><gtr:title>Nucleotide Pool Depletion Induces G-Quadruplex-Dependent Perturbation of Gene Expression.</gtr:title><gtr:parentPublicationTitle>Cell reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/10b00abb6639deb0f2c4ae66ba6f3bd3"><gtr:id>10b00abb6639deb0f2c4ae66ba6f3bd3</gtr:id><gtr:otherNames>Papadopoulou C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:outcomeId>56dcb717c3d2c0.61142850</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>30FE103E-1070-44E1-88C8-A07DC3889ED2</gtr:id><gtr:title>FANCJ coordinates two pathways that maintain epigenetic stability at G-quadruplex DNA.</gtr:title><gtr:parentPublicationTitle>Nucleic acids research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1822b7d57957392304cea9af011ee513"><gtr:id>1822b7d57957392304cea9af011ee513</gtr:id><gtr:otherNames>Sarkies P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0305-1048</gtr:issn><gtr:outcomeId>kx5rt1fxyQf</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EACBA59E-0B33-4F6C-81AF-41B499432DEB</gtr:id><gtr:title>Homologous Recombination and Translesion DNA Synthesis Play Critical Roles on Tolerating DNA Damage Caused by Trace Levels of Hexavalent Chromium.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/15f7538f139150062a0198cf42183fa9"><gtr:id>15f7538f139150062a0198cf42183fa9</gtr:id><gtr:otherNames>Tian X</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>58b06e3d5fa2f3.57956434</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2A5BD67F-95FC-40C9-B089-9652339CA72A</gtr:id><gtr:title>In vivo evidence for translesion synthesis by the replicative DNA polymerase d.</gtr:title><gtr:parentPublicationTitle>Nucleic acids research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c6fd2076082c145a5903128fba5fa1ee"><gtr:id>c6fd2076082c145a5903128fba5fa1ee</gtr:id><gtr:otherNames>Hirota K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0305-1048</gtr:issn><gtr:outcomeId>58b06e3c75ba84.26204437</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>924F1595-38C4-40FD-A8D4-CD5ED6CD0186</gtr:id><gtr:title>Timing matters: error-prone gap filling and translesion synthesis in immunoglobulin gene hypermutation.</gtr:title><gtr:parentPublicationTitle>Philosophical transactions of the Royal Society of London. Series B, Biological sciences</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/75600966f699da66eb980b17b485574a"><gtr:id>75600966f699da66eb980b17b485574a</gtr:id><gtr:otherNames>Sale JE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0962-8436</gtr:issn><gtr:outcomeId>pm_14101_11_19008194</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8558AF33-88E1-4AB5-9FA6-68F9BF2B14AA</gtr:id><gtr:title>RAD18-independent ubiquitination of proliferating-cell nuclear antigen in the avian cell line DT40.</gtr:title><gtr:parentPublicationTitle>EMBO reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/261e281297e7e91aa8ea8a2e378cc1ac"><gtr:id>261e281297e7e91aa8ea8a2e378cc1ac</gtr:id><gtr:otherNames>Simpson LJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1469-221X</gtr:issn><gtr:outcomeId>87C5ED82EE8</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>79A02EF3-8DE2-4EF9-A467-05CC1E3A930A</gtr:id><gtr:title>The dominant role of proofreading exonuclease activity of replicative polymerase e in cellular tolerance to cytarabine (Ara-C).</gtr:title><gtr:parentPublicationTitle>Oncotarget</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/18d9a05543de19a264c2a6efe73a531e"><gtr:id>18d9a05543de19a264c2a6efe73a531e</gtr:id><gtr:otherNames>Tsuda M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1949-2553</gtr:issn><gtr:outcomeId>5a9d36687ec357.40401955</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EC2D46AD-D593-42E6-8FA0-4A34CF3140DF</gtr:id><gtr:title>Measurement of diversification in the immunoglobulin light chain gene of DT40 cells.</gtr:title><gtr:parentPublicationTitle>Methods in molecular biology (Clifton, N.J.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/75600966f699da66eb980b17b485574a"><gtr:id>75600966f699da66eb980b17b485574a</gtr:id><gtr:otherNames>Sale JE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1064-3745</gtr:issn><gtr:outcomeId>pm_14101_21_22941620</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EC291FC0-1A15-4C2C-82D5-6A550EDA5284</gtr:id><gtr:title>Sequestration of CDH1 by MAD2L2 prevents premature APC/C activation prior to anaphase onset.</gtr:title><gtr:parentPublicationTitle>The Journal of cell biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1ffbe8ad9d5f883df4c7113c4ef8aa05"><gtr:id>1ffbe8ad9d5f883df4c7113c4ef8aa05</gtr:id><gtr:otherNames>Listovsky T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0021-9525</gtr:issn><gtr:outcomeId>pm_14101_21_24100295</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>41D89383-26E6-4194-9E4B-8266367681D8</gtr:id><gtr:title>Contribution of epigenetic landscapes and transcription factors to X-chromosome reactivation in the inner cell mass.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fb08b5e4bab54dc9c335adafdf208da2"><gtr:id>fb08b5e4bab54dc9c335adafdf208da2</gtr:id><gtr:otherNames>Borensztein M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn><gtr:outcomeId>5a9e84d69e04e1.48628826</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>117A97BA-B90F-429E-B03D-E142FD6AD251</gtr:id><gtr:title>Propagation of histone marks and epigenetic memory during normal and interrupted DNA replication.</gtr:title><gtr:parentPublicationTitle>Cellular and molecular life sciences : CMLS</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1822b7d57957392304cea9af011ee513"><gtr:id>1822b7d57957392304cea9af011ee513</gtr:id><gtr:otherNames>Sarkies P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1420-682X</gtr:issn><gtr:outcomeId>pm_14101_21_21964926</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DC0F490B-2C2B-4DDC-9B9A-159023BFADB2</gtr:id><gtr:title>Monitoring I-SceI-induced double-strand break repair in DT40 cells.</gtr:title><gtr:parentPublicationTitle>Methods in molecular biology (Clifton, N.J.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6eb0513fb1d9ac697137da07c0109ab0"><gtr:id>6eb0513fb1d9ac697137da07c0109ab0</gtr:id><gtr:otherNames>Plessis Dd</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1064-3745</gtr:issn><gtr:outcomeId>pm_14101_21_22941617</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>53823A0D-AB87-47BD-B800-80844BBDFD91</gtr:id><gtr:title>Role for RAD18 in homologous recombination in DT40 cells.</gtr:title><gtr:parentPublicationTitle>Molecular and cellular biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4e0fdc2a29fb7b10e8080bf594637d9e"><gtr:id>4e0fdc2a29fb7b10e8080bf594637d9e</gtr:id><gtr:otherNames>Sz?ts D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0270-7306</gtr:issn><gtr:outcomeId>A46F036D459</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B56CD7E0-15E0-4B10-B89A-6DE60340C42C</gtr:id><gtr:title>REV7/MAD2L2: the multitasking maestro emerges as a barrier to recombination.</gtr:title><gtr:parentPublicationTitle>The EMBO journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/75600966f699da66eb980b17b485574a"><gtr:id>75600966f699da66eb980b17b485574a</gtr:id><gtr:otherNames>Sale JE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0261-4189</gtr:issn><gtr:outcomeId>564203b239d7a6.89110722</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>404C6B3F-1575-4DD5-BC24-089040E2832C</gtr:id><gtr:title>Y-family DNA polymerases and their role in tolerance of cellular DNA damage.</gtr:title><gtr:parentPublicationTitle>Nature reviews. Molecular cell biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/75600966f699da66eb980b17b485574a"><gtr:id>75600966f699da66eb980b17b485574a</gtr:id><gtr:otherNames>Sale JE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1471-0072</gtr:issn><gtr:outcomeId>pm_14101_21_22358330</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>23195780-43F5-4D0C-9768-C53ACB31B983</gtr:id><gtr:title>RAD18 and poly(ADP-ribose) polymerase independently suppress the access of nonhomologous end joining to double-strand breaks and facilitate homologous recombination-mediated repair.</gtr:title><gtr:parentPublicationTitle>Molecular and cellular biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ff1e7eebb9258f68b07d7f0f04106099"><gtr:id>ff1e7eebb9258f68b07d7f0f04106099</gtr:id><gtr:otherNames>Saberi A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0270-7306</gtr:issn><gtr:outcomeId>C89AE99D8AC</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C06B15EF-5C16-441D-9066-886A0B59877C</gtr:id><gtr:title>Starting over: Primpol reprimes after chain termination.</gtr:title><gtr:parentPublicationTitle>Cell cycle (Georgetown, Tex.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/75600966f699da66eb980b17b485574a"><gtr:id>75600966f699da66eb980b17b485574a</gtr:id><gtr:otherNames>Sale JE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1551-4005</gtr:issn><gtr:outcomeId>58b06e3cc12508.45863584</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MC_U105178808</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>F3822669-BB5A-4BB4-BAE0-DCB9DE36E092</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Generic Health Relevance</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>